AMSTERDAM, Jan. 9, 2025 /PRNewswire/ -- Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug ...
Oct 28 (Reuters) - Innate Pharma SA : * Presents at World ADC Summit two posters showing new sets of preclinical data on its new, site-specific conjugation technology (BTG-ADC) Sign up here. * ADCs ...
License agreement centered around development of a single ADC program Usage of Synaffix GlycoConnect®, HydraSpace® and toxSYN® ADC technologies to enhance efficacy, tolerability and target engagement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback